Cargando…

Is it time to reform oversight of clinical gene therapy in the EU?

Detalles Bibliográficos
Autor principal:	Kenter, Marcel J.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303196/ https://www.ncbi.nlm.nih.gov/pubmed/30341921 http://dx.doi.org/10.1111/bcp.13795

Ejemplares similares

Monitoring and oversight in critical care research
por: Lavery, James V, et al.
Publicado: (2004)

Test and trace strategy has overlooked importance of clinical input, clinical oversight and integration
por: Harding-Edgar, Louisa, et al.
Publicado: (2020)

Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee
por: Byrne, Michael, et al.
Publicado: (2023)

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
por: Inglesby, Thomas V., et al.
Publicado: (2020)

Re: “The next phase of human gene-therapy oversight”
por: Yamato, Masayuki
Publicado: (2019)

Promoting Healthy Growth or Feeding Obesity? The Need for Evidence-Based Oversight of Infant Nutritional Supplement Claims
por: Lampl, Michelle, et al.
Publicado: (2016)

Oversight of EU medical data transfers – an administrative law perspective on cross-border biomedical research administration
por: Reichel, Jane
Publicado: (2017)

Rigorous review and editorial oversight of clinical preprints
por: Zaidi, Mone, et al.
Publicado: (2021)

The medicolegal landscape through the lens of COVID-19: time for reform
por: Mehta, Arpan R, et al.
Publicado: (2020)

EU regulation of gene-edited plants—A reform proposal
por: Voigt, Brigitte
Publicado: (2023)

FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012)

The Global Fund’s paradigm of oversight, monitoring, and results in Mozambique
por: Warren, Ashley, et al.
Publicado: (2017)

The National Clinical Impact Awards: cosmetic change or fundamental reform?
por: Essex, Ryan, et al.
Publicado: (2022)

Testosterone therapy in the new era of Food and Drug Administration oversight
por: Desroches, Bethany, et al.
Publicado: (2016)

Policy perspectives for healthcare reforms
por: Mutatkar, R. K.
Publicado: (2015)

Regulatory Oversight and Safety of Probiotic Use
por: Venugopalan, Veena, et al.
Publicado: (2010)

The Trouble With Too Much Board Oversight
por: Hoitash, Udi
Publicado: (2013)

Heads of Clinical Observations on Mistakes and Oversights in the Treatment of Strangulated Hernia
por: Mayo, Herbert
Publicado: (1834)

Achieving effective informed oversight by DMCs in COVID clinical trials
por: DeMets, David L., et al.
Publicado: (2020)

Four Fallacies and an Oversight: Searching for Martian Life
por: Rummel, J.D., et al.
Publicado: (2017)

Good collaborative practice: reforming capacity building governance of international health research partnerships
por: Ward, Claire Leonie, et al.
Publicado: (2018)

The IRB structure and medical research reform
por: Babyar, Julie
Publicado: (2018)

Policy entrepreneurship in the reform of pediatric dentistry
por: Edelstein, Burton L., et al.
Publicado: (2017)

The need to reform our assessment of evidence from clinical trials: A commentary
por: Bagshaw, Sean M, et al.
Publicado: (2008)

Health reform in Mexico: governance and potential outcomes
por: León-Cortés, Jorge L., et al.
Publicado: (2019)

US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016)

Oversight and Management of Women with Psoriasis in Childbearing Age
por: Bucur, Ștefana, et al.
Publicado: (2022)

Bringing Opportunity Oversight Onto the Board's Agenda
por: Leonard, Frank
Publicado: (2013)

Corporate governance, board oversight, and CEO turnover
por: Laux, Volker
Publicado: (2014)

The Macroeconomic Imbalance Procedure at the Heart of EU Economic Governance Reform
por: Koll, Willi, et al.
Publicado: (2022)

The Liaison of Isotype Class Switch and Mismatch Repair: An Illegitimate Affair
por: Kenter, Amy L.
Publicado: (1999)

Sino-EU Intergovernmental Collaboration in the Campaign Against the COVID-19 Pandemic on Food via EU-China-Safe Framework
por: Wu, Di, et al.
Publicado: (2021)

Research ethics oversight in Norway: structure, function, and challenges
por: Froud, R., et al.
Publicado: (2019)

Carrier detection in childhood: a need for policy reform
por: Ross, Lainie Friedman
Publicado: (2010)

Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014)

Maximizing the potential of psychology for the Israeli mental health reform
por: Huppert, Jonathan D
Publicado: (2014)

Outsourcing: how to reform WHO for the 21st century
por: Negin, Joel, et al.
Publicado: (2016)

Towards an equitable internship programme at WHO: is reform nigh?
por: Barnett-Vanes, Ashton, et al.
Publicado: (2016)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
por: Diallo, Alpha, et al.
Publicado: (2022)

Oversight in Surgical Innovation: A Response to Ethical Challenges
por: Gupta, Saksham, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bbsd2geihalq8vsl12t8olt35m